Leiomyosarkoma Treatment in Uni-asia Cancer hospital

Treatment for leiomyosarcoma is available at Uni-asia Cancer Hospital in Chengdu, China, where a multidisciplinary team specializes in minimally invasive tumor therapy. An online consultation with an oncologist may cost around $150, while advanced imaging like a PET/CT or a whole-body CT scan typically runs $1,300. The facility is known for managing complex solid tumors using a personalized approach across two specialized campuses.

Care is led by Prof. Dr. Liao Zhengyin, a Chief Physician with over 30 years of experience. A senior visiting scholar at Johns Hopkins Hospital in the USA, Prof. Dr. Liao has performed 40,000+ procedures. He is a pioneer in cryoablation and radioactive seed implantation, focusing on interventional oncology for difficult cases.

Diagnostic options

• Online consultation with oncologist. Patients can receive a remote evaluation and treatment plan.
• CT scan of the whole body. This helps locate the primary tumor and check for spread.
• PET/CT. This high-resolution imaging helps distinguish active tumor tissue from scar tissue.

Minimally invasive and surgical treatments

The clinic uses several methods to treat localized and recurrent leiomyosarcoma. For tumors near critical blood vessels, doctors use NanoKnife ablation. This non-thermal technique uses electrical pulses to destroy cancer cells while protecting healthy ducts and vessels.

• Wide local excision surgery. Surgeons remove the tumor with negative margins to prevent local recurrence.
• Cryoablation (Argon-Helium knife). This technique freezes tumor tissue under precise imaging guidance.
• Radiofrequency and microwave ablation. These methods use heat to destroy lung metastases or local recurrences.
• Interventional embolization. This procedure cuts off the blood supply to hypervascular sarcomas.
• Iodine-125 seed implantation. Small radioactive seeds provide localized radiation for tumors that cannot be removed by surgery.

Advanced therapy and limb preservation

For sarcomas located in the arms or legs, the hospital offers regional limb perfusion. This technique delivers high doses of chemotherapy directly to the limb while protecting the rest of the body. This approach helps avoid amputation and maintains physical function. Patients may also receive targeted and immunotherapy, which uses drugs to attack specific genetic mutations in the cancer cells. This systemic therapy is often combined with traditional chemoradiotherapy to improve long-term outcomes.

To learn more about the treatment options for leiomyosarcoma, you may request a consultation on Bookimed.